Long COVID did not create a crisis. It exposed one. Patients without clear diagnoses lose access to care, coverage, and credibility. When medicine cannot measure your illness, the system moves on. Here is what that looks like and who pays the price

US healthcare does not fail when it denies care. It performs as designed. This essay involving the life of Jace Yawnick examines how insurance incentives, prior authorization, and employer based coverage shape access, delay treatment, and shift risk onto patients while increasing total cost.

Brain cancer at 21 forced Matthew Zachary into the American healthcare system decades before he understood its economics, incentives, and failures. At 52, he reflects on how surviving long enough to see the whole machine clearly led to writing We the Patients.

Patients now need executive level skills to survive diagnosis, treatment, and access. This essay featuring Kathy Giusti breaks down how healthcare incentives create that reality, who benefits, who pays, and what must change to reduce risk and restore accountability.

Thirty years after brain cancer, Matthew Zachary returned to the piano at Merkin Hall for MZLIVE, a night that became far more than a concert. Survivors, advocates, clinicians, and healthcare leaders confronted what survivorship actually costs and what the system still refuses to see

At 19, Shlomit Liberty lost speech and got sent home with “stress.” Now she spends 15 to 20 hours a week guiding families through hospital chaos. This episode exposes how discharge, insurance rules, and system incentives leave patients confused and paying the price.

We the Patients officially launches today and is already in its second printing before release day. Matthew Zachary shares why readers across healthcare, advocacy, and survivorship circles are responding so strongly to a book that names the realities patients live through every day.

After 30 years inside the healthcare system, Matthew Zachary watches his story and thousands of others come to life in a cinematic trailer for We the Patients and explains why this project now reaches far beyond a book.

I paid $13.18 for a 90 day prescription through Cost Plus. Walgreens charged $30 with insurance. Same drug. Same supply. This is what PBMs do to pricing and why transparency exposes the middlemen.

American healthcare delays care and denies treatment by design. Insurance rules, prior authorization, and administrative barriers control access to care, often slowing or blocking what doctors recommend and patients need.

Monique Gore Massy spent 2.5 years misdiagnosed while lupus shut her body down. This episode exposes bias, diagnostic delay, and the cost of dismissing patients who “look fine,” and what happens when lived experience demands real authority.